Opinion

Video

Evolving Treatment Standards in Non-Clear Cell RCC

Author(s):

Martin H. Voss, MDMoshe Ornstein, MD

Martin H. Voss, MD, and Moshe Ornstein, MD, engage in a professional discourse concerning the current treatment standards and the evolving therapeutic landscape for non-clear cell renal cell carcinoma (RCC).

  1. How has the treatment landscape evolved for patients with advanced nccRCC?
  • What are the available treatment options for patients with advanced nnRCC?
  • How are you choosing between the available options?
Related Videos
5 KOLs are featured in this program
5 KOLs are featured in this program
5 KOLs are featured in this panel.
5 KOLs are featured in this panel.
5 KOLs are featured in this series.
5 KOLs are featured in this series.
5 KOLs are featured in this panel.
5 KOLs are featured in this panel.
2 KOLs are featured in this panel.
2 KOLs are featured in this panel.
Related Content